High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx

Laryngoscope

Volumn 109, Issue 12, 1999, Pages 1967-1973

  Rudoltz, Marc S ^a,c,d   Perkins, Ryan S ^a,c   Luthmann, Robert W ^a,c   Fracke, Todd D ^a   Green, Tina M ^a   Moye, Linda ^a   Wludyka, Peter ^b   Choi, Young Ku ^b   Ackerman, Scot N ^a,c  

^a St Vincent's Medical Center Jacksonville   (United States)

^b UNIVERSITY OF NORTH FLORIDA   (United States)

^c First Coast Oncology   (United States)

^d First Coast Oncology   (United States)

Author keywords

High dose rate brachytherapy; Local control; Oral cavity; Oropharynx; Radiotherapy; Squamous cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BEAM THERAPY; BONE NECROSIS; BRACHYTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE;

EID: 0032704313     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199912000-00013     Document Type: Article

References (43)

1. Thawley S, O'Leary M. Malignant neoplasms of the oropharynx. In: Cummings C, ed. Otolaryngology - Head Neck Surgery. St. Louis, MO: Mosby-Year Book, 1993: 1306-1354.
2. Baker S. Malignant neoplasms of the oral cavity. In Cummings C, ed. Otolaryngology - Head and Neck Surgery. edn 2. St. Louis, MO: Mosby-Year Book, 1993:1248-1305
3. Amdur R, Parsons J, Mendenhall W, Million R, Stringer S, Cassisi N. Postoperative radiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications. Int J Radiat Oncol Biol Phys 1989;16:25-36.
4. Mendenhall W, Parsons J, Stringer S, Cassisi N, Million R. T2 oral tongue carcinoma treated with radiotherapy: analysis of local control and complications. Radiother Oncol 1989;16:275-281.
5. Pernot M, Malissard L, Aletti P, Hoffstetter S, Forcard J, Bey P. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: comparison of two treatment regimens. Radiother Oncol 1992;23:223-228.
6. Wallner P, Hanks G, Kramer S, McLean C. Patterns of care study: analysis of outcome survey data-anterior two-thirds of tongue and floor of mouth. Am J Clin Oncol 1986;9:50-57.
7. Wendt C, Peters L, Delclos L, et al. Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy. Int J Radiat Oncol Biol Phys 1990;18: 1287-1292.
8. Bachaud J, Delannes M, Allouache N, et al. Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth. Radiother Oncol 1994;31:199-206.
9. Pernot M, Hoffstetter S, Peiffert D, et al. Epidermoid carcinomas of the floor of mouth treated by exclusive irradiation: statistical study of a series of 207 cases. Radiother Oncol 1995;35:177-185.
10. Garrett P, Beale F, Cummings B, et al. Carcinoma of the tonsil: the effect of dose-time-volume factors on local control. Int J Radiat Oncol Biol Phys 1985;11:703-706.
11. Goffinet D, Fee W, Wells J, et al. 192Ir pharyngoepiglottic fold interstitial implants: the key to successful treatment of base of tongue carcinoma by radiation therapy. Cancer 1985;192I(55):941-948.
12. Harrison L, Sessions R, Strong E, Fass D, Nori D, Fuks Z. Brachytherapy as part of the definitive management of squamous cancer of the base of tongue. Int J Radiat Oncol Biol Phys 1989;17:1309-1312.
13. Harrison L, Zelefsky M, Sessions R, et al. Base-of-tongue cancer treated with external beam irradiation plus brachytherapy: oncologic and functional outcome. Radiology 1992;184:267-270.
14. Horiot J. Interstitial brachytherapy in velo-tonsillar tumors: the ultimate boost. Int J Radiat Oncol Biol Phys 1995;31: 1021-1022.
15. Housset M, Baillet F, Dessard-Diana B, Martin D, Miglianico L. A retrospective study of three treatment techniques for T1-T2 base of tongue lesions: surgery plus postoperative radiation, external radiation plus interstitial implantation and external radiation alone. Int J Radiat Oncol Biol Phys 1987;13:511-516.
16. Leborgne J, Leborgne F, Barlocci L, Ortega B. The place of brachytherapy in the treatment of the tonsil with lingual extension. Int J Radiat Oncol Biol Phys 1986;12:1787-1792.
17. Mazeron J, Crook J, Martin M, Peynegre R, Pierquin B. Iridium 192. implantation of squamous cell carcinomas of the oropharynx. Am J Otolaryngol 1989;192:10.: 317-321.
18. Nag S, Owen J, Farnan N, et al. Survey of brachytherapy practice in the United States: a report of the Clinical Research Committee of the American Endocurietherapy Society. Int J Radiat Oncol Biol Phys 1995;31:103-107.
19. Rudoltz M, Benammar A, Mohiuddin M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Physics 1993; 26:767-772.
20. Horiot J, Le Fur R, N'Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992; 25:231-241.
21. American Joint Committee on Cancer. AJCC Cancer Staging Manual. edn 5. Philadelphia: Lippincott-Raven Publishers, 1997.
22. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
23. Cox D. Regression models and life tables. J Royal Stat Soc 1972;34:1870-1920.
24. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972;29:1446-1449.
25. Cole D, Patel P, Matar J, Kenady D, Maruyama Y. Floor of mouth cancer. Arch Otolaryngol Head Neck Surg 1994;120: 260-263.
26. Mazeron J, Crook J, Marinello G, Walop W, Pierquin B. Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated with iridium 192 implantation. Int J Radiat Oncol Biol Phys 1990;19:281-285.
27. Mazeron J, Grimard L, Raynal M, et al. Iridium-192 curietherapy for T1 and T2 epidermoid carcinomas of the floor of mouth. Int J Radiat Oncol Biol Phys 1990;18: 1299-1306.
28. Mazeron J, Crook J, Benck V, et al. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 1990;19:1369-1376.
29. DeCroix Y, Ghossein N. Experience of the Curie Institute in treatment of cancer of the mobile tongue, I: treatment policies and results. Cancer 1981;47:496-502.
30. Benk V, Mazeron J, Grimard L, et al. Comparison of curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinomas of the mobile tongue. Radiother Oncol 1990;18:339-347.
31. Donath D, Vuong T, Shenouda G, MacDonald B, Tabah R. The potential uses of high-dose-rate brachytherapy in patients with head and neck cancer. Eur Arch Otorhinolaryngol 1995;252:321-324.
32. Friedrich R, Krull A, Hellner D, et al. Interstitial high-dose rate brachytherapy with iridium-192 in patients with oral squamous cell carcinoma. J Craniomaxillofac Surg 1995; 23:238-242.
33. Lau H, Hay J, Flores A, Threlfall W. Seven fractions of twice daily high dose-rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio. Radiother Oncol 1996;39:15-18.
34. Leung T, Wong V, Wong C, et al. High dose rate brachytherapy for carcinoma of the oral tongue. Int J Radiat Oncol Biol Physics 1997;39:1113-1120.
35. Amichetti M, Romano M, Busana L, et al. Hyperfractionated radiation in combination with local hyperthermia in the treatment of advanced squamous cell carcinoma of the head and neck: a phase I-II study. Radiother Oncol 1997; 45:155-158.
36. Behar R, Martin P, Fee W, Goffinet D. Iridium-192 interstitial implant and external beam radiation therapy in the management of squamous cell carcinomas of the tonsil and soft palate. Int J Radiat Oncol Biol Phys 1994;28:221-227.
37. Crook J, Mazeron J, Marinello G, et al. Combined external radiation and interstitial implantation for T1 and T2 epidermoid carcinomas of the base of tongue: the Creteil experience. Int J Radiat Oncol Biol Phys 1988;15: 105-114.
38. Puthawala A, Syed A, Eads D, Gillin L, Gates T. Limited external beam and interstitial 192 iridium irradiation in the treatment of carcinoma of the base of the tongue: a ten year experience. Int J Radiat Oncol Biol Phys 1988;14:839-848.
39. Brizel D, Albers M, Fisher S, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338: 1798-1804.
40. Wendt T, Grabenbauer G, Rodel C, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998;16:1318-1324.
41. Inoue T, Inoue T, Yamazaki H, et al. High dose rate versus low dose rate interstitial radiotherapy for carcinoma of the floor of mouth. Int J Radiat Oncol Biol Phys 1998;41: 53-58.
42. Levendag P, Schmitz P, Jansen P, et al. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys 1997; 38:497-506.
43. Inoue T, Inoue T, Teshima T, et al. Phase III trial of high and low dose rate interstitial radiotherapy for early tongue cancer. Int J Radiat Oncol Biol Phys 1996;36:1201-1204.